Founded in 2000, CureVac is a global clinical-stage biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA) technology for the development of prophylactic vaccines, cancer therapies, antibody therapies and the treatment of protein therapies.
from RTT - Biotech https://ift.tt/2PLfOqI
via IFTTT
No comments:
Post a Comment